Performant Healthcare downgraded to Neutral from Buy at B. Riley

Written by Emily J. Thompson, Senior Investment Analyst

PHLT%

Updated: Aug 04 2025

0mins

Downgrade and Acquisition Details: B. Riley downgraded Performant Healthcare from Buy to Neutral, raising the price target to $7.75 following its acquisition agreement with Machinify for $670M, or $7.75 per share.
Board Approval and Timeline: The acquisition deal was unanimously approved by Performant's board and is anticipated to close by the end of 2025.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Performant Healthcare downgraded to Neutral from Buy at B. Riley

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

4D Molecular Therapeutics Grants 23,600 RSUs to New Employees

Tesla (TSLA) Nears Completion of AI5 Chip Design, AI6 Development Underway

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch